These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh),Mozambique, and Uganda. Yang W; Parisi M; Lahue BJ; Uddin M; Bishai D Vaccine; 2014 Nov; 32(49):6643-8. PubMed ID: 25306911 [TBL] [Abstract][Full Text] [Related]
23. The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia. Krudwig K; Knittel B; Karim A; Kanagat N; Prosser W; Phiri G; Mwansa F; Steinglass R Vaccine; 2020 Aug; 38(37):5905-5913. PubMed ID: 32703746 [TBL] [Abstract][Full Text] [Related]
24. Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial Optimization for Cost Savings. Fukudo M; Ishikawa R; Mishima K; Ono T; Matsumoto S; Tasaki Y JCO Oncol Pract; 2020 Oct; 16(10):e1134-e1142. PubMed ID: 32496875 [TBL] [Abstract][Full Text] [Related]
25. Impact of wastage on single and multi-dose vaccine vials: Implications for introducing pneumococcal vaccines in developing countries. Parmar D; Baruwa EM; Zuber P; Kone S Hum Vaccin; 2010 Mar; 6(3):. PubMed ID: 20009517 [TBL] [Abstract][Full Text] [Related]
26. Sterility assessment of multiple use botulinum A exotoxin vials: a prospective simulation. Alam M; Yoo SS; Wrone DA; White LE; Kim JY J Am Acad Dermatol; 2006 Aug; 55(2):272-5. PubMed ID: 16844511 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of external contamination on the vial surfaces of some hazardous drugs that commonly used in Chinese hospitals and comparison between environmental contamination generated during robotic compounding by IV: Dispensing robot vs. manual compounding in biological safety cabinet. Ml H; T W; Jq Z; Yj S; Tj G; Lk Z; J L; Jf Y J Oncol Pharm Pract; 2022 Oct; 28(7):1487-1498. PubMed ID: 34162245 [TBL] [Abstract][Full Text] [Related]
28. "Product on Stopper" in a Lyophilized Drug Product: Cosmetic Defect or a Product Quality Concern? Mehta SB; Roy S; Yang HC J Pharm Sci; 2018 Jun; 107(6):1736-1740. PubMed ID: 29432763 [TBL] [Abstract][Full Text] [Related]
29. Effect of adverse storage conditions on performance of glucometer test strips. Bamberg R; Schulman K; MacKenzie M; Moore J; Olchesky S Clin Lab Sci; 2005; 18(4):203-9. PubMed ID: 16315736 [TBL] [Abstract][Full Text] [Related]
30. Closed System Transfer Devices (CSTDs): Understanding Potential Over- and Under- Dosing of Liquid Vial Drug Products and How to Generally Mitigate. Lehermayr C; Schmelzer B; Kropf M J Pharm Sci; 2023 Sep; 112(9):2532-2537. PubMed ID: 37146755 [TBL] [Abstract][Full Text] [Related]
32. Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs. Forshay CM; Streeter SO; Salch SA; Eckel SF J Oncol Pharm Pract; 2019 Jul; 25(5):1160-1166. PubMed ID: 30041583 [TBL] [Abstract][Full Text] [Related]
33. Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital. Chan HK; Lim YM Asian Pac J Cancer Prev; 2016 Nov; 17(11):4951-4957. PubMed ID: 28032722 [TBL] [Abstract][Full Text] [Related]
34. Sterility and concentration of liposomal bupivacaine single-use vial when used in a multiple-dose manner. Carlson AR; Nixon E; Jacob ME; Messenger KM Vet Surg; 2020 May; 49(4):772-777. PubMed ID: 31943286 [TBL] [Abstract][Full Text] [Related]
35. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating. Allen LV; Okeke CC Int J Pharm Compd; 2008; 12(4):344-53. PubMed ID: 23969772 [TBL] [Abstract][Full Text] [Related]
36. Sterility and use patterns of multiple-dose vials. Bawden JC; Jacobson JA; Jackson JC; Anderson RK; Burke JP Am J Hosp Pharm; 1982 Feb; 39(2):294-7. PubMed ID: 6800255 [TBL] [Abstract][Full Text] [Related]
37. Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States. Hess LM; Cui ZL; Li XI; Oton AB; Shortenhaus S; Watson IA J Med Econ; 2018 Aug; 21(8):755-761. PubMed ID: 29673274 [TBL] [Abstract][Full Text] [Related]
38. Hazardous Drug Contamination of Drug Preparation Devices and Staff: A Contamination Study Simulating the Use of Chemotherapy Drugs in a Clinical Setting. Call E; Bill B; McLean C; Call N; Bernkopf A; Oberg C Hosp Pharm; 2017 Sep; 52(8):551-558. PubMed ID: 29276288 [No Abstract] [Full Text] [Related]